A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins
Solution-based affinity assays are used for the selection and characterization of proteins that could be developed into therapeutic molecules. However, these assays have limitations for cell-surface proteins as in most cases their purification requires detergent solubilization and are unlikely to assume conformations in solution that resemble their native states in cell membranes. This report describes a novel electrochemiluminescence-based method, called MSD-CAT, for the affinity analysis of antibodies binding to cell-surface receptors. MSD-CAT was used to evaluate the binding of monoclonal antibodies, Fab fragments, and bispecific antibodies targeting the cell-surface receptor interleukin 3 receptor alpha (CD123) and the results were compared to data obtained using surface plasmon resonance (SPR). The data showed that MSD-CAT can be successfully applied to determine binding affinity on cells in a label free format and without the need for laborious solubilization procedures to generate recombinant antigen. In addition, this method has the potential for high-throughput application while enabling simultaneous determination of equilibrium dissociation constant (K<sub>D</sub>) and receptor density within the same experiment.
Authors
- Deborah Kwok
- Jennifer F. Nemeth
- Rupesh Nanjunda
- Scott L. Klakamp (ORCID: https://orcid.org/0000-0002-1231-9655)
- Steven Jacobs (ORCID: https://orcid.org/0000-0002-8083-8916)
- Gordon Powers
- Eilyn R. Lacy
- H. Hugo Caicedo
Institutions
- Johnson & Johnson (United States) (US)
- Eli Lilly (United States) (US)
- Coherus BioSciences (United States) (US)
- Johnson & Johnson (Israel) (IL)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1038/s41598-024-82288-9
- Citations
- 1
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 1.36